Ince Semra, Emer Ozdes, Deveci Salih, Okuyucu Kursat, Alagoz Engin, San Huseyin, Ayan Aslı, Karacalioglu Ozgur, Haymana Cem, Gunalp Bengul, Arslan Nuri
Department of Nuclear Medicine, University of Health Sciences, Gulhane Training and Research Hospital, Ankara, Turquía.
Department of Nuclear Medicine, University of Health Sciences, Gulhane Training and Research Hospital, Ankara, Turquía.
Rev Esp Med Nucl Imagen Mol (Engl Ed). 2018 Jul-Aug;37(4):205-210. doi: 10.1016/j.remn.2017.12.006. Epub 2018 May 2.
Parathyroid scintigraphy (PS) can be negative or equivocal (N/E) in a considerable number of cases with highly suspicious clinical findings and biochemical results for parathyroid adenoma (PA). The aims of this study were to investigate the complementary role of parathormone washout test (PWT) to PS in patients with primary hyperparathyroidism (PHPT) and evaluate histopathologic aspects of PAs in comparison with PS results.
Thirty-eight patients with PHPT referred for PS were included in the study. Seventeen patients had both scintigraphic and ultrasonographic findings concordant with PA (Group A). Twenty-one patients having N/E PS, but suspected lesions for PA on ultrasonography (US) formed Group B. PWT was performed for all patients and they underwent the surgical intervention. An adenoma was removed in all patients and the histopathologic cell characteristics were established.
The tumor size on US was larger in those patients whose adenomas were seen on the PS (P<.001). The percentages of chief (or principal), oxyphilic and clear cells in PAs were not statistically different between the groups. Serum parathormone level and PWT were not statistically significant between Group A and Group B (P=.095 and P=.04, respectively).
Although there is not a definitive threshold value, the sensitivity of PS increases with lesion size. While chief cell and oxyphilic cell content of PAs tend to deplete in N/E PS, clear cell rate increases substantially. Combining PS with both US and PWT increases the sensitivity of detection and localization of PAs.
在相当数量临床高度怀疑甲状旁腺腺瘤(PA)且生化检查结果支持的病例中,甲状旁腺闪烁扫描(PS)可能呈阴性或结果不明确(N/E)。本研究旨在探讨甲状旁腺激素洗脱试验(PWT)对原发性甲状旁腺功能亢进症(PHPT)患者PS的补充作用,并与PS结果相比较评估PA的组织病理学特征。
本研究纳入38例因PS而转诊的PHPT患者。17例患者的闪烁扫描和超声检查结果均与PA相符(A组)。21例PS结果为N/E但超声检查(US)怀疑有PA病变的患者组成B组。对所有患者进行PWT检查,之后均接受手术干预。所有患者均切除腺瘤并确定组织病理学细胞特征。
PS检查发现腺瘤的患者,其US显示的肿瘤大小更大(P<0.001)。两组PA中主细胞(或 chief cell)、嗜酸性细胞和透明细胞的百分比无统计学差异。A组和B组之间血清甲状旁腺激素水平和PWT无统计学意义(分别为P = 0.095和P = 0.04)。
尽管没有明确的阈值,但PS的敏感性随病变大小增加。在PS结果为N/E的PA中,主细胞和嗜酸性细胞含量趋于减少,而透明细胞率大幅增加。将PS与US和PWT相结合可提高PA检测和定位的敏感性。